Iterum Therapeutics Stock Forecast - Daily Balance Of Power

ITRM Stock  USD 1.80  0.18  9.09%   
Iterum Stock Forecast is based on your current time horizon. Although Iterum Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Iterum Therapeutics' systematic risk associated with finding meaningful patterns of Iterum Therapeutics fundamentals over time.
  
As of the 14th of December 2024, Inventory Turnover is likely to drop to -1.17. In addition to that, Payables Turnover is likely to drop to 0.33. As of the 14th of December 2024, Common Stock Shares Outstanding is likely to drop to about 12.3 M. In addition to that, Net Loss is likely to drop to about (42 M).
On December 12, 2024 Iterum Therapeutics PLC had Daily Balance Of Power of (0.09). Balance of Power indicator (or BOP) measures the strength of Iterum Therapeutics PLC market sensitivity to bulls and bears. It estimates the ability of Iterum Therapeutics buyers and sellers to push price to an extreme high or extreme low level. As a result, by monitoring Iterum Therapeutics Balance of Power indicator one can determine a trend of the price direction.
Check Iterum Therapeutics VolatilityBacktest Iterum TherapeuticsTrend Details  

Iterum Therapeutics Trading Date Momentum

On December 13 2024 Iterum Therapeutics PLC was traded for  1.80  at the closing time. The top price for the day was 2.05  and the lowest listed price was  1.78 . The trading volume for the day was 2.6 M. The trading history from December 13, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 9.09% . The trading delta at closing time against the current closing price is 0.51% .
Balance of Power indicator was created by Igor Livshin to predict asset short term price movements or warning signals. If Balance of Power indicator is trended towards the high of its range it will signify that the bulls are in control. On the other hand when the BOP indicator is moving towards the lows of its range it signifies that the bears are in control. If the indicator move from a high positive range to a lower positive range it signifies that the buying pressure is decreasing. Conversely, if the indicator move from a low negative range to a higher negative range it signifies that the selling pressure is decreasing.
Compare Iterum Therapeutics to competition

Other Forecasting Options for Iterum Therapeutics

For every potential investor in Iterum, whether a beginner or expert, Iterum Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Iterum Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Iterum. Basic forecasting techniques help filter out the noise by identifying Iterum Therapeutics' price trends.

Iterum Therapeutics Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Iterum Therapeutics stock to make a market-neutral strategy. Peer analysis of Iterum Therapeutics could also be used in its relative valuation, which is a method of valuing Iterum Therapeutics by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Iterum Therapeutics PLC Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Iterum Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Iterum Therapeutics' current price.

Iterum Therapeutics Market Strength Events

Market strength indicators help investors to evaluate how Iterum Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Iterum Therapeutics shares will generate the highest return on investment. By undertsting and applying Iterum Therapeutics stock market strength indicators, traders can identify Iterum Therapeutics PLC entry and exit signals to maximize returns.

Iterum Therapeutics Risk Indicators

The analysis of Iterum Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Iterum Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting iterum stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Iterum Therapeutics PLC is a strong investment it is important to analyze Iterum Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Iterum Therapeutics' future performance. For an informed investment choice regarding Iterum Stock, refer to the following important reports:
Check out Historical Fundamental Analysis of Iterum Therapeutics to cross-verify your projections.
You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Iterum Therapeutics. If investors know Iterum will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Iterum Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.76)
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.73)
Return On Equity
(5.56)
The market value of Iterum Therapeutics PLC is measured differently than its book value, which is the value of Iterum that is recorded on the company's balance sheet. Investors also form their own opinion of Iterum Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Iterum Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Iterum Therapeutics' market value can be influenced by many factors that don't directly affect Iterum Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Iterum Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Iterum Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Iterum Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.